A randomised study of Agent A with Agent B against Agent C in the treatment of non-severe Plasmodium falciparum malaria

ISRCTN	ISRCTN13706172
DOI	https://doi.org/10.1186/ISRCTN13706172
Protocol serial number	N0263115165
Sponsor	Department of Health (UK)
Funder	University College London Hospitals NHS Trust (UK)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr C Whitty
Scientific

Hospital for Tropical Diseases
Mortimer Market
Capper Street
London
WC1E 6JD
United Kingdom

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Is Agent A better treatment than Agent B for patients with mild moderate falciparum malaria?
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Infections and Infestations: Malaria
Intervention	Randomised controlled trial: A. Quinine and Fabsidar B. Malarone
Intervention type	Drug
Phase	Not Specified
Drug / device / biological / vaccine name(s)	Quinine, Fabsidar, Malarone
Primary outcome measure(s)	1. Time to full recovery 2. Side effects of treatment 3. Relapse of malaria.
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	01/07/2006

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target sample size at registration	400
Key inclusion criteria	400 Patients from Infectious/Tropical Diseases.
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/07/2002
Date of final enrolment	01/07/2006

Hospital for Tropical Diseases

London
WC1E 6JD
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan